G C Cotzias, P S Papavasiliou, R Gellene. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedAgranulocytosis/chemically inducedAromatic Amino Acid Decarboxylase InhibitorsBlood Urea NitrogenBlood-Brain Barrier/drug effectsChronic DiseaseDihydroxyphenylalanine/administration & dosageDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/metabolismDihydroxyphenylalanine/toxicityDihydroxyphenylalanine/urineDopamine/urineFeeding and Eating Disorders/chemically inducedFemaleHumansHuntington Disease/drug therapyMaleManganese/bloodMental Processes/drug effectsMethyldopa/administration & dosageMiddle AgedMovement Disorders/chemically inducedNausea/chemically inducedNeurologic ManifestationsParkinson Disease/drug therapyPhenylacetates/urinePlacebosThyroid Function TestsTyrosine/metabolismVomiting/chemically induced
Substances: See more » Aromatic Amino Acid Decarboxylase InhibitorsPhenylacetatesPlacebosTyrosineManganeseMethyldopaDihydroxyphenylalanineDopamine
Year: 1969 PMID: 4178641 DOI: 10.1056/NEJM196902132800701
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245